Advertisement

x

Mathews Journal of Pharmaceutical Science

2474-753X

FAQ's


Q: What are the Open Access Journals are available in your Publishing group?
Ans: Please visit the mentioned link [email protected] to view the list of Journals that are available with us.


Q: How can I submit my paper?
The candidate can submit Manuscript in email to [email protected] or submit from the Journal Web page


Q: What is the time required to publish my paper?
Ans: The peer process will take a minimum of 30 business days. After peer revise process, it will be published within 3 days after acceptance of the paper.


Q: How can I join as Reviewer to this Journal?
Ans: You can write your interest in email to [email protected] and we will get back to you in 3-4 days.
 

Q: Do Editor have to work continuously?
Ans: No, the editorial office will be helping you whenever required as we understand that you may be busy in other commitments.


Q: Whom do I have to contact at the Editorial office if I have any queries?
Ans: Kindly email your query to [email protected]. Editorial office or the respective Journal Managing Editor will respond you in 3-4 days.


Q: What is the eligibility if I would like to review a manuscript?
Ans: The reviewers are assigned by the Editors as per the research matching to the topic of manuscript. Self registered peer reviewers must be having a few published papers in the field of interest they mentioned. 


Q: Do you charge for a manuscript submission?
Ans: There are no charges for manuscript submission. The authors only need to pay the article processing charges once the article is accepted.
 
Q: Is there any limit to review papers?
Ans: No. You may review as many manuscripts you wish according to manuscript topic match your interest.


Q: Why should an author pay the article processing charge?
In Open Access mode of publication, the scholarly literature will be made available to the researchers free of cost without any subscription charges. The whole maintenance of the operations i.e production of full text and PDF formats as well as archiving and indexing the published articles permanently through the article processing charges only. However, fee discounts will be provided to the authors from low income countries (According to World Bank classification).

Recently Published Articles
Research Article

Synthesis and Antidiseas Evaluation of Some Bis-Heteroaryls (Thiophene or Selenophene) 1,2,3-triazoles C-trimethylsilylated

Published : 28th June 2024
Authors : Paolo Zanirato1,*, Silvia Businelli2
Citation : Zanirato P, et al. (2024). Synthesis and Antidiseas Evaluation of Some Bis-Heteroaryls (Thiophene or Selenophene) 1,2,3-triazoles C-trimethylsilylated. Mathews J Pharma Sci. 8(1):29.

Research Article

Formulation, In-Vitro and In-Vivo Evaluation of Lamivudine-Loaded Solid Lipid Nanoparticles (SLNs)

Published : 13th June 2024
Authors : Amarachi Salome Chime1, Chekwube Andrew Ezegbe1,3,* Chidinma Judith Iyanyi1, Chukwunwike Godswill Onunkwo1, Amarachi Grace Ezegbe2, Nnedimma Pauline Okafor1
Citation : Chime AS, et al. (2024). Formulation, In-Vitro and In-Vivo Evaluation of Lamivudine-Loaded Solid Lipid Nanoparticles (SLNs). Mathews J Pharma Sci. 8(1):28.

Research Article

The Battle of the Physic and Chemistry against Pathogenic Microorganism

Published : 18th May 2024
Authors : Ferruccio Trifirò*, Paolo Zanirato#
Citation : Trifirò F, et al. (2024). The Battle of the Physic and Chemistry against Pathogenic Microorganism. Mathews J Pharma Sci. 8(1):27.

Research Article

Regulatory Update on eSubmissions in Balkans

Published : 01st April 2024
Author : Marjan Dzeparoski1,2,*
Citation : Dzeparoski M. (2024). Regulatory Update on eSubmissions in Balkans. Mathews J Pharma Sci. 8(1):26.

Research Article

Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment

Published : 11th December 2023
Authors : Aria Hajihassan1, Atena Zandi1, Ghazal Esmaeili1, Mostafa Norizadeh2,3,*
Citation : Hajihassan A, et al. (2023). Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment. Mathews J Pharma Sci. 7(4):25.

Research Article

Quality of Life and Medication Adherence in Rheumatoid Arthritis Patients

Published : 25th November 2023
Authors : Qadeer Ahmed, Muhammad Talha, Umer Ishtiaq, Saba Khurshid, Kaif Akbar, Urwa Amir, Muhammad Rehan, Ovais Ullah Shirazi, Shahid Latif, Zunaira Akbar, Iram Batool, Ali Akhtar*, Samreen Fatima
Citation : Ahmed Q, et al. (2023). Quality of Life and Medication Adherence in Rheumatoid Arthritis Patients. Mathews J Pharma Sci. 7(4):24.

Indexed
Root Indexing
WolrdCat
J Gate
Directory of Research Journals Indexing
International Scientific Indexing
Genamics JournalSeek
Scientific Indexing Services
International Committee of Medical Journal Editors
Scilit
CiteFactor
Google Scholar
Subscribe

Subscribe to our RSS feed, be in touch with our articles, news, videos, reebies.

Antispam Code Generate new code

Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com